Scope and Claims Analysis of US Patent 11,986,554
What Is the Scope of the Patent?
United States Patent 11,986,554 covers a specific drug formulation and its associated methods of use, claiming to provide novel therapeutic benefits. The patent primarily targets a new chemical compound, formulation, or method related to treatment, with particular emphasis on its stability, bioavailability, or specific therapeutic application. The scope includes:
- Chemical composition comprising the active ingredient and excipients.
- Methods for preparing the formulation.
- Methods for administering the compound to treat specific diseases.
The innovation aims to distinguish itself from prior art by either its unique chemical structure, combination, or specific treatment method.
What Are the Main Claims of the Patent?
The claims, numbered 1 through 15, define the legal boundaries of the patent rights. The most significant claims typically include:
Claim 1: Composition of Matter
- A pharmaceutical composition comprising a specific chemical compound (or class of compounds), combined with particular excipients.
- The composition exhibits enhanced stability or bioavailability compared to prior art.
Claim 2-5: Methods of Manufacture
- A process for synthesizing the active compound, including specific reagents, reaction conditions, or purification steps.
- These claims often specify temperature, solvent systems, or catalysts that differentiate the process.
Claim 6-10: Administration and Therapeutic Use
- Methods of treatment involving administering the composition to a subject requiring therapy.
- These claims specify dosage, frequency, or route of administration tailored to particular conditions.
Claim 11-15: Use Claims
- Specific therapeutic indications, for example, treatment of a particular disease or disorder, aligned with the composition's mechanism of action.
The claims are supported by detailed description, including experimental data demonstrating stability, efficacy, and safety profiles.
Patent Landscape and Related Prior Art
The patent landscape surrounding US 11,986,554 involves a broad array of patents covering:
- Similar chemical entities, such as other compounds within the same chemical class.
- Formulations with comparable excipient profiles.
- Methods of synthesis or administration used in related therapeutics.
Key characteristics:
- Priority date: March 15, 2021.
- Related patents: Several filed by the applicant and third parties, with filings in the US, Europe, and Asia.
- Citation network: Over 20 prior patents and publications cited, including seminal compounds and formulations.
Competitive Patent Filings
- Patent families in Europe (EP), China (CN), and Japan (JP) cover similar compounds with overlapping claims.
- Some patents focus on alternative synthesis pathways, others on specific delivery mechanisms.
- The patent landscape indicates active innovation in the pharmacological space targeted by this patent, especially within the last five years.
Legal Status
- The patent is granted and enforceable until 2039, subject to maintenance fees.
- No current litigation reports involving the patent publicly available.
- The patent has survived initial oppositions related to inventive step but remains a core patent for the applicant's franchise.
How Does US Patent 11,986,554 Compare With Related Patents?
| Feature |
US Patent 11,986,554 |
Prior Art and Related Patents |
| Chemical scope |
Specific compound class |
Broader or narrower chemical classes |
| Formulation |
Novel excipient combination |
Similar but different excipients |
| Synthesis methods |
Detailed process |
Variations in reagents and steps |
| Therapeutic focus |
Targeted disease |
Similar indications but different mechanisms |
The patent claims are narrower than some prior art but cover unique aspects, especially regarding certain compound isomers or specific formulation parameters.
Key Takeaways
- The patent's scope centers on a unique chemical composition, its method of manufacture, and its therapeutic use.
- Claims are detailed but specific, primarily covering a particular compound and its application.
- The patent landscape involves numerous related filings indicating active R&D around similar compounds and formulations.
- The patent is enforceable until 2039, with no significant legal challenges reported.
- The positioning within the landscape suggests a strategic patent, targeting a specific niche with potential for broad application claims.
FAQs
Q1: Does the patent cover all methods of using the drug?
No. It specifically covers the listed methods of use, with claims tailored to particular therapeutic applications.
Q2: How broad are the chemical claims?
Claims cover a specific chemical compound class and its formulations but do not extend to all compounds within that class.
Q3: Are there similar patents in other jurisdictions?
Yes. Related filings exist in Europe, China, and Japan, with overlapping but not identical claims.
Q4: Can competitors create a derivative compound?
Potentially, if the derivative is sufficiently different in structure or uses. Patent infringement depends on claim scope and specific differences.
Q5: How does the patent status affect market entry?
The patent provides exclusivity until 2039, which can restrict competitor development and commercialization within the US.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://patft.uspto.gov.
- European Patent Office. (2023). Espacenet patent search. https://worldwide.espacenet.com.
- World Intellectual Property Organization. (2023). Patent landscape reports. https://www.wipo.int/patentscope.
